2-acetylaminofluorene has been researched along with Cystitis in 1 studies
2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
Cystitis: Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shinohara, Y | 1 |
| Frith, CH | 1 |
| Greenman, DL | 1 |
1 other study available for 2-acetylaminofluorene and Cystitis
| Article | Year |
|---|---|
Correlation of urothelial morphologic characteristics with the development of bladder carcinomas in BALB/c female mice administered 2-acetylaminofluorene.
Topics: 2-Acetylaminofluorene; Animals; Cystitis; Female; Hyperplasia; Lymphocytes; Metaplasia; Mice; Mice, | 1982 |